Global (AMER, EMEA, BRICS and APAC) Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2019-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Infectious Disease Point of Care Diagnostics Market



Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results. Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites. Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection. It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections. In 2018, the global Infectious Disease Point of Care Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in United States, Europe and China. 

Market Segmentation, Outlook & Regional Insights: Infectious Disease Point of Care Diagnostics Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
 
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits

Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:

Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Key Players, Recent Developments & Sector Viewpoints: Infectious Disease Point of Care Diagnostics Market
 
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Key Insights Covered: Exhaustive Infectious Disease Point of Care Diagnostics Market
1.  Market size (sales, revenue and growth rate) of Infectious Disease Point of Care Diagnostics industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Infectious Disease Point of Care Diagnostics industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Infectious Disease Point of Care Diagnostics industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Infectious Disease Point of Care Diagnostics industry.

Research Methodology: Infectious Disease Point of Care Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.